From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Lipid Management>
  4. Archives

Lipid Management: Archives

Some content may require paid access to the site. Subscribe or purchase a seven-day site pass for the full text of all our clinical perspectives on medical journal articles, guidelines, and news.

Items 201-225 of 354 are shown

Weighing In on Statin Use in Children

The main effect of the updated 2008 guidelines likely will be an increase in lipid screening in children with unknown family histories or additional risk factors.

Statin Use and Incident Cognitive Impairment or Dementia

A prospective cohort study suggests a protective effect from statins.

Statin Side Effects — Targets of Ongoing Research

In particular, researchers are looking at cognitive and musculoskeletal effects of statins.

Hemorrhagic Stroke in an Atorvastatin Stroke-Prevention Trial

Analysis of the hemorrhagic-stroke events in the SPARCL study demonstrates higher risk in certain subgroups, independent of the statin.

More Trouble for Ezetimibe

Questions have arisen about a possible association with cancer.

Recertification Scores Correlate with Quality of Care

Some indicators of quality of care were positively associated with top scores on the internal medicine recertification exam.

How Fat Am I? Or, How Am I Fat?

Two new studies address how obesity relates to cardiovascular risk factors.

Stormy SEAS

Unexpected findings from a trial of simvastatin plus ezetimibe raise questions about the effects of aggressive LDL-cholesterol reduction.

Navigating Uncharted Waters

In contrast to a recent trial’s findings, an analysis of pooled data from two trials of ezetimibe plus simvastatin finds no increase in cancer risk, but the voyage has just begun.

Should Apolipoproteins Replace LDL and HDL for Cardiac Risk Assessment?

Apolipoproteins were better predictors in both sexes and in all ethnic and age groups.

Renewed Warning About Combining Simvastatin and Amiodarone

The FDA issued a reminder about heightened risk for rhabdomyolysis with this combination but provided few details to assist in clinical decision making.

Lipid Screening in Childhood — New Recommendations from the AAP

Controversial new recommendations advocate wider screening and use of statins in children.

Statins and Cognitive Impairment

Findings from a prospective observational study support the thesis that statin use may protect against the eventual development of dementia.

Statin-Induced Myopathy: A Genetic Association

A strong link is found between two SNPs and an adverse drug effect, but a useful clinical role for pharmacogenetic testing is still a long way off.

Apolipoprotein B100/Apolipoprotein A-1 Ratio Better Than Cholesterol-Based Methods for Risk Prediction

Results from the INTERHEART study fuel an ongoing controversy.

Simvastatin and Cognitive Function in Children with NF

No cognitive benefit was noted in children with neurofibromatosis type 1, but their cholesterol levels dropped.

Lipid Screening in Childhood — New Recommendations from the AAP

Controversial new recommendations advocate wider screening and use of statins in children.

The Diet Debate: Mediterranean, Low-Fat, or Low-Carb?

In a randomized trial, the Mediterranean and low-carbohydrate diets performed as well as or better than the low-fat diet.

More Details on Lipids and Stroke

Triglycerides and non-HDL cholesterol correlated with large-artery atherosclerosis in a cohort of patients with stroke or TIA.

ABCA1 Mutations Not Associated With Ischemic Heart Disease

A genetic association study casts doubt on what we think we know about HDL.

CETP Genotypes and Cardiovascular Risk

Results of a large systematic review suggest that the CETP pathway may yet prove a worthwhile target for preventive intervention.

Erectile Dysfunction: A New Risk Factor for Heart Disease

Results of two new studies make a strong case for including ED in cardiovascular risk assessment.

Aggressive Statin Treatment After Bypass Surgery

In a retrospective analysis of patients who had previously undergone CABG, a higher dose of atorvastatin was associated with better outcomes than a lower dose.

In Meta-Analysis, Asymptomatic Carotid Bruit Predicts Cardiovascular Events

For cardiovascular risk assessment, a simple inexpensive technique might be as useful as costly imaging studies.

How Often Do We Need to Check Cholesterol Levels?

Adherent patients with well-controlled cholesterol levels could be monitored every 3 to 5 years.

Items 201-225 of 354 are shown

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?





Copyright © 2013. Massachusetts Medical Society. All rights reserved.